Director, Global Regulatory Affairs
Spring House Pennsylvania UNITED STATES
Over the course of her 30-year career in the pharmaceutical industry, Melody has contributed to small and large molecule oncology drug development, led a regulatory intelligence team, and provided Global Regulatory leadership for Janssen’s cell therapy/delivery system combination product. Reflecting her passion for learning and innovation, she is currently leading a Cross-Sector regulatory team focused on the introduction of Digital/Healthcare Technologies in Clinical Trials while she continues to coordinate J&J’s Cross-Sector Global Regulatory policy efforts in the cell therapy space. Melody completed her B.S. and Doctor of Pharmacy degrees at the State University of New York at Buffalo and completed an ASHP Accredited Post-Doctoral Residency in Oncology Pharmacy in San Antonio, Texas.